CLLS
CellectisDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
CLLS vs peer average
45/100
CLLS vs. peer average (D vs. D)
Grade spread
A 1 · B 1 · C 1 · D 4 · F 3
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
NKTX is the first available peer comparator.
Closest packet comparator for development-stage cell-therapy catalyst volatility, but differing targets and programs limit clinical read-through.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
CLLS
Cellectis
NKTX
Nkarta
Grade
D
D
Momentum
95
70
Value
41
41
Sentiment
52
55
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs NKTX
CLLS / NKTX
Grade Position
In line
CLLS vs. peer average (D vs. D)
45/100
Momentum
95
CLLSValue
41
CLLSSentiment
52
NKTXRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs CLLS
NKTX is the first peer returned for this comparison set.